Viewing Study NCT04709458


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-01 @ 8:38 AM
Study NCT ID: NCT04709458
Status: UNKNOWN
Last Update Posted: 2022-05-03
First Post: 2021-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
Sponsor: Taiga Biotechnologies, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module